10-Q: Nordson Q1 Earnings Soar 40.9% on Strong Sales, Investment Gain

Nordson Corporation reported a significant 40.9% increase in net income for the first fiscal quarter ended January 31, 2026, driven by robust sales growth across key segments and a substantial unrealized gain on a minority investment.

Summary

• Net income increased by 40.9% to $133,382 thousand ($2.38 diluted EPS) for the three months ended January 31, 2026, compared to $94,652 thousand ($1.65 diluted EPS) in the prior year.
• Total sales grew 8.8% to $669,461 thousand from $615,420 thousand year-over-year.
• Operating profit rose 18.1% to $166,405 thousand from $140,947 thousand.
• Gross margin slightly improved to 54.7% from 54.6%.
• Advanced Technology Solutions (ATS) segment led sales growth with a 23.1% increase, driven by electronics dispense and recovering x-ray system demand.
• Industrial Precision Solutions (IPS) sales increased 8.8%, with organic growth of 3.2% primarily in Asia Pacific.
• Medical and Fluid Solutions (MFS) sales were flat at -0.2%, but organic sales grew 2.7% due to fluid solutions product lines.
• A significant unrealized gain of $22,238 thousand on a publicly listed minority investment contributed substantially to other income.
• The company repurchased $86,001 thousand in common shares and paid $45,786 thousand in dividends.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a very positive report, driven by strong top-line growth, significant profit expansion, and a substantial non-operating gain, indicating robust operational execution and effective capital management.

Positives

• Net income surged 40.9% to $133,382 thousand, with diluted EPS up 44.2% to $2.38.
• Total sales increased 8.8% to $669,461 thousand.
• Operating profit grew 18.1% to $166,405 thousand.
• Gross margin slightly improved to 54.7%.
• ATS segment showed strong sales growth of 23.1% (20.7% organic) and EBITDA margin improvement of 300 basis points.
• MFS segment achieved 2.7% organic sales growth and a 310 basis point EBITDA margin increase due to favorable mix from divestiture and strong incremental performance.
• A substantial unrealized gain of $22,238 thousand from a minority investment significantly boosted other income.
• Interest expense decreased by 11.2% due to lower average debt levels.
• Effective tax rate remained stable at 18.9% (vs. 19.0% prior year).
• Strong cash flow generation allowed for $86,001 thousand in share repurchases and $45,786 thousand in dividends.
• The company entered into a new $1,200,000 thousand senior unsecured multicurrency revolving credit facility, extending maturity to January 2031.

Negatives

• IPS segment EBITDA decreased 380 basis points despite higher sales, attributed to unfavorable product and geographic mix.
• Americas region experienced a total sales decrease of 2.2% (0.4% organic, 2.9% from acquisitions/divestitures).
• Net cash provided by operating activities decreased by $18,694 thousand to $140,428 thousand.
• MFS segment total sales decreased by 0.2% due to a 4.3% impact from acquisitions/divestitures, despite organic growth.
• Foreign currency losses of $2,294 thousand were included in Other income net for the current quarter, compared to gains of $331 thousand in the prior year.

Risks

• U.S. and international economic and political conditions.
• Financial and market conditions.
• Currency exchange rates and devaluations.
• Possible acquisitions and the company's ability to complete and successfully integrate them.
• The company's ability to successfully divest or dispose of businesses that do not fit its strategic plan.
• Effects of changes in U.S. trade policy and trade agreements, including tariffs.
• Effects of changes in tax law.
• Possible effects of events beyond control, such as political unrest (including the conflicts in Europe and the Middle East), acts of terror, natural disasters, and pandemics.
• Contractual restriction from selling shares in a publicly listed minority investment until December 2028.

Future Outlook

The company leverages a scalable growth framework expected to deliver top-tier growth with leading margins and returns. It anticipates adoption of ASU 2023-09 in fiscal 2026 and ASU 2024-03 in fiscal 2028. Cash from operations, combined with available borrowing capacity and ready access to capital markets, is expected to be more than adequate to fund liquidity needs over the next twelve months and the foreseeable future thereafter.

Management Comments

• "Nordson is an innovative precision technology company that leverages a scalable growth framework expected to deliver top tier growth with leading margins and returns."
• "Our strategy for long-term growth is based on solving customers needs globally."
• "The Company is well-positioned to manage liquidity needs that arise from working capital requirements, capital expenditures, contributions related to pension and postretirement obligations, principal and interest payments on our outstanding debt, dividends, and share repurchases."
• "The Company believes it has the ability to generate and obtain adequate amounts of cash to meet its short-term and long-term needs for cash."

Industry Context

StockSavvy.ai notes that Nordson's strong performance in Advanced Technology Solutions, particularly in electronics dispense and x-ray systems, aligns with broader industry trends of increasing demand for precision manufacturing and quality control in the electronics sector. The growth in Medical and Fluid Solutions also reflects the resilient demand in the medical device industry. The slight decline in Americas sales, however, could indicate regional economic softness or competitive pressures.

Comparison to Industry Standards

• The filing does not provide specific comparisons to comparable companies, projects, or industry benchmarks.

Corporate Governance

Legal Proceedings

• Involved in pending or potential litigation regarding environmental, product liability, patent, contract, employee, and other matters arising from the normal course of business.
• Management does not believe that losses in excess of accrued amounts would have a material adverse effect on financial condition, operating results, or cash flows.

Stakeholder Impact

• Shareholders: Benefited from increased net income, diluted EPS, and ongoing share repurchases and dividends.
• Employees: No specific direct impact mentioned, but the company has approximately 8,200 employees worldwide.
• Customers: Benefited from the company's focus on solving customer needs globally and delivering proprietary dispensing and processing technology.
• Creditors: The company is in compliance with all debt covenants and has strong liquidity, indicating low credit risk.

Next Steps

• Continue to assess the impact of the One Big Beautiful Bill Act (OBBBA) for the year ending October 31, 2026.
• Anticipate adoption of ASU 2023-09 in fiscal 2026 in the Annual Report on Form 10-K for the year ending October 31, 2026.
• Anticipate adoption of ASU 2024-03 in fiscal 2028.
• Management will continue to manage liquidity needs from working capital, capital expenditures, pension/postretirement obligations, debt payments, dividends, and share repurchases.
• The share repurchase program does not have an expiration date and will continue to be funded by cash from operations and borrowings.

Key Dates

Recommendation

The company delivered exceptional Q1 results with significant growth in net income and EPS, driven by strong sales across key segments and a substantial non-operating gain. The improved gross margin, reduced interest expense, and effective capital allocation through share repurchases and dividends demonstrate robust financial health and management efficiency. The new, larger revolving credit facility further strengthens liquidity and financial flexibility. While the IPS segment's EBITDA margin declined due to mix, the overall performance, particularly in high-growth ATS and MFS organic sales, positions Nordson for continued strong performance.

Keywords

Nordson, NDSN, Q1 2026, earnings, financial results, precision technology, dispensing, medical devices, electronics, industrial solutions, SEC filing, 10-Q, share repurchase, revenue, net income, EPS, EBITDA, corporate governance, capital resources